N95 Respirators vs Medical Masks in Outpatient Settings-Reply

Lewis J. Radonovich; Michael S. Simberkoff; Trish M. Perl

doi:10.1001/jama.2019.20908

N95 Respirators vs Medical Masks in Outpatient Settings-Reply

Lewis J. Radonovich, Michael S. Simberkoff, Trish M. Perl

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	789-790
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	323
Issue number	8
DOIs	https://doi.org/10.1001/jama.2019.20908
State	Published - Feb 25 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2019.20908

Cite this

@article{6ee6dffdd5c64eeaa378dde0ec5dc553,

title = "N95 Respirators vs Medical Masks in Outpatient Settings-Reply",

author = "Radonovich, {Lewis J.} and Simberkoff, {Michael S.} and Perl, {Trish M.}",

note = "Funding Information: Apple and the Medtronic Foundation; and grants and personal fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, and Pfizer. Dr Berwanger reported receipt of grants and personal fees from AstraZeneca, Bayer, and Boehringer Ingelheim; grants from Amgen and Roche Diagnosis; and personal fees from Novo Nordisk and Novartis. No other disclosures were reported.",

year = "2020",

month = feb,

day = "25",

doi = "10.1001/jama.2019.20908",

language = "English (US)",

volume = "323",

pages = "789--790",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - N95 Respirators vs Medical Masks in Outpatient Settings-Reply

AU - Radonovich, Lewis J.

AU - Simberkoff, Michael S.

AU - Perl, Trish M.

N1 - Funding Information: Apple and the Medtronic Foundation; and grants and personal fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, and Pfizer. Dr Berwanger reported receipt of grants and personal fees from AstraZeneca, Bayer, and Boehringer Ingelheim; grants from Amgen and Roche Diagnosis; and personal fees from Novo Nordisk and Novartis. No other disclosures were reported.

PY - 2020/2/25

Y1 - 2020/2/25

UR - http://www.scopus.com/inward/record.url?scp=85080960889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080960889&partnerID=8YFLogxK

U2 - 10.1001/jama.2019.20908

DO - 10.1001/jama.2019.20908

M3 - Letter

C2 - 32096844

AN - SCOPUS:85080960889

SN - 0098-7484

VL - 323

SP - 789

EP - 790

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 8

ER -

N95 Respirators vs Medical Masks in Outpatient Settings-Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this